Literature DB >> 8041866

Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea.

D Lalloo1, D Fisher, S Naraqi, I Laurenson, P Temu, A Sinha, A Saweri, B Mavo.   

Abstract

Cryptococcal meningitis is a common cause of chronic meningitis in Papua New Guinea, affecting apparently immunocompetent people. The majority of infections are believed to be due to Cryptococcus neoformans var. gattii. We have reviewed the records of 49 Melanesian adults who presented with proven cryptococcal meningitis to the University teaching hospital in Port Moresby, and compare our findings with other published studies of cryptococcal meningitis in the tropics and sub-tropics. None of the patients had an obvious cause of immunosuppression. Visual disturbances and fundoscopic changes of papilloedema or papillitis were particularly common. The in-hospital case fatality rate for patients treated with amphotericin B and flucytosine was 22.4%. Of the fully treated patients, 31% became completely blind before being discharged from hospital. Therapy directly aimed at reducing intracranial pressure may improve outcome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041866

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  13 in total

1.  Deafness and blindness in a HIV-positive patient with cryptococcal meningitis.

Authors:  J L Prada; J Torre-Cisneros; J M Kindelan; R Jurado; J L Villanueva; M Navarro; M J Linares
Journal:  Postgrad Med J       Date:  1996-09       Impact factor: 2.401

Review 2.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1.

Authors:  Jeremy N Day; Thu N Hoang; Anh V Duong; Chau T T Hong; Pham T Diep; James I Campbell; Tran P M Sieu; Tran T Hien; Tien Bui; Maciej F Boni; David G Lalloo; Dee Carter; Stephen Baker; Jeremy J Farrar
Journal:  J Clin Microbiol       Date:  2010-12-15       Impact factor: 5.948

Review 4.  Management of Cryptococcus gattii meningoencephalitis.

Authors:  Carlos Franco-Paredes; Tanea Womack; Teri Bohlmeyer; Brenda Sellers; Allison Hays; Kalpesh Patel; Jairo Lizarazo; Shawn R Lockhart; Wajid Siddiqui; Kieren A Marr
Journal:  Lancet Infect Dis       Date:  2014-11-26       Impact factor: 25.071

5.  Cryptococcosis in HIV negative patients: findings on chest radiography.

Authors:  D J Roebuck; D A Fisher; B J Currie
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

6.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

7.  Ophthalmic manifestations of Cryptococcus gattii species complex: a case series and review of the literature.

Authors:  Grace A McCabe; Jack W McHugh; Todd Goodwin; Douglas F Johnson; Anthony Fok; Thomas G Campbell
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

8.  Cryptococcus gattii infections in multiple states outside the US Pacific Northwest.

Authors:  Julie R Harris; Shawn R Lockhart; Gail Sondermeyer; Duc J Vugia; Matthew B Crist; Melissa Tobin D'Angelo; Brenda Sellers; Carlos Franco-Paredes; Monear Makvandi; Chad Smelser; John Greene; Danielle Stanek; Kimberly Signs; Randall J Nett; Tom Chiller; Benjamin J Park
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

9.  Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest.

Authors:  Rachel M Smith; Adamma Mba-Jonas; Mathieu Tourdjman; Trisha Schimek; Emilio DeBess; Nicola Marsden-Haug; Julie R Harris
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

Review 10.  Cryptococcal meningitis: epidemiology and therapeutic options.

Authors:  Derek J Sloan; Victoria Parris
Journal:  Clin Epidemiol       Date:  2014-05-13       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.